These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 1377606)

  • 1. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases.
    Chung J; Kuo CJ; Crabtree GR; Blenis J
    Cell; 1992 Jun; 69(7):1227-36. PubMed ID: 1377606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.
    Kuo CJ; Chung J; Fiorentino DF; Flanagan WM; Blenis J; Crabtree GR
    Nature; 1992 Jul; 358(6381):70-3. PubMed ID: 1614535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.
    Monfar M; Lemon KP; Grammer TC; Cheatham L; Chung J; Vlahos CJ; Blenis J
    Mol Cell Biol; 1995 Jan; 15(1):326-37. PubMed ID: 7528328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells.
    Fruman DA; Wood MA; Gjertson CK; Katz HR; Burakoff SJ; Bierer BE
    Eur J Immunol; 1995 Feb; 25(2):563-71. PubMed ID: 7533090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes.
    Fingar DC; Hausdorff SF; Blenis J; Birnbaum MJ
    J Biol Chem; 1993 Feb; 268(4):3005-8. PubMed ID: 7679106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of MAP kinases, pp90rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or Fc epsilon RI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells.
    Tsai M; Chen RH; Tam SY; Blenis J; Galli SJ
    Eur J Immunol; 1993 Dec; 23(12):3286-91. PubMed ID: 7504992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.
    Price DJ; Grove JR; Calvo V; Avruch J; Bierer BE
    Science; 1992 Aug; 257(5072):973-7. PubMed ID: 1380182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
    Sadoshima J; Izumo S
    Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase.
    Chung J; Grammer TC; Lemon KP; Kazlauskas A; Blenis J
    Nature; 1994 Jul; 370(6484):71-5. PubMed ID: 8015612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.
    Chou MM; Blenis J
    Cell; 1996 May; 85(4):573-83. PubMed ID: 8653792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line.
    Albers MW; Williams RT; Brown EJ; Tanaka A; Hall FL; Schreiber SL
    J Biol Chem; 1993 Oct; 268(30):22825-9. PubMed ID: 8226793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the immunosuppressant rapamycin.
    Dumont FJ; Su Q
    Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of p70/p85 S6 kinase activities in T cells by dexamethasone.
    Monfar M; Blenis J
    Mol Endocrinol; 1996 Sep; 10(9):1107-15. PubMed ID: 8885245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin.
    Calvo V; Crews CM; Vik TA; Bierer BE
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7571-5. PubMed ID: 1380162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional analysis of pp70S6k.
    Cheatham L; Monfar M; Chou MM; Blenis J
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11696-700. PubMed ID: 8524831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.
    Yao R; Cooper GM
    Oncogene; 1996 Jul; 13(2):343-51. PubMed ID: 8710373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of 70-kDa S6 kinase, induced by the cytokines interleukin-3 and erythropoietin and inhibited by rapamycin, is not an absolute requirement for cell proliferation.
    Calvo V; Wood M; Gjertson C; Vik T; Bierer BE
    Eur J Immunol; 1994 Nov; 24(11):2664-71. PubMed ID: 7957559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites.
    Han JW; Pearson RB; Dennis PB; Thomas G
    J Biol Chem; 1995 Sep; 270(36):21396-403. PubMed ID: 7545671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.
    Marx SO; Jayaraman T; Go LO; Marks AR
    Circ Res; 1995 Mar; 76(3):412-7. PubMed ID: 7532117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking CD28 leads to activation of 70-kDa S6 kinase.
    Pai SY; Calvo V; Wood M; Bierer BE
    Eur J Immunol; 1994 Oct; 24(10):2364-8. PubMed ID: 7523138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.